Protein antigens useful for cancer therapy and vaccination
摘要
<p>The present invention relates to the use of highly immunogenic protein antigens for vaccination and immunotherapy of cancer in humans and animals. In particular, the present invention relates to the use of a wild-type or a recombinant mycobacterial PstS1 protein or wild-type or recombinant Hsp16 protein for the preparation of a vaccine or therapeutical composition for the treatment of cancer, in particular for the treatment of urothelial carcinoma of the bladder or mama carcinoma.</p>
申请公布号
EP1508338(A1)
申请公布日期
2005.02.23
申请号
EP20030019169
申请日期
2003.08.22
申请人
LIONEX DIAGNOSTICS AND THERAPEUTICS GMBH
发明人
SINGH, MAHAVIR, PROF.DR.;BOEHLE, ANDREAS, PROF.DR.;SAENGER, CHRISTIAN, DR.;BRANDAU, SVEN, DR.